• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic

tetano

Editor, Senior Moderator
Front Immunol


. 2024 Jun 7:15:1363572.
doi: 10.3389/fimmu.2024.1363572. eCollection 2024. New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic

Jonatan J Carvajal[SUP] #[/SUP][SUP] 1 [/SUP], Valeria García-Castillo[SUP] #[/SUP][SUP] 1 [/SUP], Shelsy V Cuellar[SUP] 1 [/SUP], Claudia P Campillay-Véliz[SUP] 2 [/SUP], Camila Salazar-Ardiles[SUP] 3 [/SUP], Andrea M Avellaneda[SUP] 1 4 [/SUP], Christian A Muñoz[SUP] 5 6 7 [/SUP], Angello Retamal-Díaz[SUP] 1 5 7 [/SUP], Susan M Bueno[SUP] 8 [/SUP], Pablo A González[SUP] 8 [/SUP], Alexis M Kalergis[SUP] 8 9 [/SUP], Margarita K Lay[SUP] 1 5 7 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the respiratory distress condition known as COVID-19. This disease broadly affects several physiological systems, including the gastrointestinal, renal, and central nervous (CNS) systems, significantly influencing the patient's overall quality of life. Additionally, numerous risk factors have been suggested, including gender, body weight, age, metabolic status, renal health, preexisting cardiomyopathies, and inflammatory conditions. Despite advances in understanding the genome and pathophysiological ramifications of COVID-19, its precise origins remain elusive. SARS-CoV-2 interacts with a receptor-binding domain within angiotensin-converting enzyme 2 (ACE2). This receptor is expressed in various organs of different species, including humans, with different abundance. Although COVID-19 has multiorgan manifestations, the main pathologies occur in the lung, including pulmonary fibrosis, respiratory failure, pulmonary embolism, and secondary bacterial pneumonia. In the post-COVID-19 period, different sequelae may occur, which may have various causes, including the direct action of the virus, alteration of the immune response, and metabolic alterations during infection, among others. Recognizing the serious adverse health effects associated with COVID-19, it becomes imperative to comprehensively elucidate and discuss the existing evidence surrounding this viral infection, including those related to the pathophysiological effects of the disease and the subsequent consequences. This review aims to contribute to a comprehensive understanding of the impact of COVID-19 and its long-term effects on human health.

Keywords: COVID-19; SARS-CoV-2; host factors; immune response; long-COVID-19; pathogenesis; pathophysiology; variants.

 
Back
Top Bottom